Skip to main content
Algernon Health Inc. logo

Algernon Health Inc. — Investor Relations & Filings

Ticker · AGN ISIN · CA3978841078 CSE Human health and social work activities
Open in API
Filings indexed 579 across all filing types
Latest filing 2021-11-24 Regulatory Filings
Country CA Canada
Listing CSE AGN

About Algernon Health Inc.

https://www.algernonhealth.com/

Algernon Health Inc. is a healthcare company focused on the provision of advanced diagnostic services, primarily through the establishment of medical clinics specializing in Alzheimer's disease. A key offering is the utilization of brain-optimized Positron Emission Tomography (PET) scanning technology for screening and imaging within a planned network of North American facilities. The company maintains a clinical-stage drug development and repurposing division, which investigates existing, approved drugs for new therapeutic applications targeting unmet global medical needs.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2021-11-24 English
Other securityholders documents - English.pdf
Share Issue/Capital Change Classification · 95% confidence The document is a formal notification to multiple Canadian securities commissions and the Canadian Depository for Securities about a share consolidation by Algernon Pharmaceuticals Inc. It includes details about the consolidation ratio (100 to 1), the expected number of shares post-consolidation, and the effective date. The document also contains a news release announcing the share consolidation and explains the process for shareholders. There are no financial statements, detailed financial analysis, or management discussion of results. The document is primarily an announcement of a capital structure change (share consolidation). This fits the definition of a Share Issue/Capital Change (SHA) filing, which covers announcements regarding new share issues, stock splits, or other capital changes. The document length is sufficient and contains substantive information about the share consolidation, not just a brief mention or a link to a report, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is SHA with high confidence.
2021-11-18 English
News release - English.pdf
Share Issue/Capital Change Classification · 100% confidence The document is an announcement by Algernon Pharmaceuticals regarding a share consolidation (a capital structure change) where the company intends to consolidate its common shares on a 100 to 1 basis. It discusses the number of shares before and after consolidation, the need for acceptance from the Canadian Securities Exchange, and the expected trading changes post-consolidation. There is no financial data, earnings information, or detailed report content. The document is clearly about a capital change event, specifically a share consolidation, which fits the category of Share Issue/Capital Change (SHA).
2021-11-18 English
News release - English.pdf
Regulatory Filings
2021-11-01 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Algernon Pharmaceuticals has received a CAD$2M cash payment from a refundable tax credit program and has submitted an application to list its common shares on the Nasdaq Capital Market. It includes forward-looking statements and general company information but does not contain any financial statements, detailed financial results, or substantive financial data. The document is relatively short (4342 characters) and serves as an update on financing and listing intentions rather than a formal financial report or detailed capital structure change. Given the content focuses on financing activities and capital market listing application, the most appropriate classification is Capital/Financing Update (CAP).
2021-10-21 English
News release - English.pdf
Regulatory Filings
2021-10-13 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.